Floatz logo

Metformin

Acanthosis Nigricans

Juan Pablo Castanedo-CazaresSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Acanthosis Nigricans cohort.

Asset / SponsorPhaseRating
LEUPROLIDE
National Center for Research Resources (NCRR)
Phase 2B
Spironolactone
National Center for Research Resources (NCRR)
Phase 2B

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →